KCP Board of Directors

Get the latest insights into the leadership at KCP. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. V L Indira Dutt Chairperson & Managing Director
Mrs. V Kavitha Dutt Joint Managing Director
Mr. C Panduranga Rao Ind. Non-Executive Director
Mr. Harish Lakshman Ind. Non-Executive Director
Mr. Thiruvengadam Parthasarathi Ind. Non-Executive Director
Mr. Ravi Chitturi Ind. Non-Executive Director
Mrs. Janaki Pillai Independent Woman Director
Mr. V Chandrakumar Prasad Non Exe.Non Ind.Director
Dr. Subbarao Vallabhaneni Non Exe.Non Ind.Director

KCP Share price

KCP

206.37

0.15 (-0.07%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:44 IST
BUYSELL
Today's High

212.20

Today's Low

205.28

52 Week Low

167.55

52 Week High

266.75

The current prices are delayed, login to your account for live prices

KCP FAQs

The board at KCP consists of experienced professionals, including Dr. V L Indira Dutt , Mrs. V Kavitha Dutt , and others, overseeing the company’s strategic and corporate governance.

Directors at KCP are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. V L Indira Dutt is the current chairman at KCP.

Executive directors at KCP are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, KCP adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At KCP, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.